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The amygdala plays a critical role in emotion processing and psychiatric disorders
associated with emotion dysfunction. Accumulating evidence suggests that amygdala
structure is modulated by serotonin-related genes. However, there is a gap between the
small contributions of single loci (less than 1%) and the reported 63–65% heritability
of amygdala structure. To understand the “missing heritability,” we systematically
explored the contribution of serotonin genes on amygdala structure at the gene
set level. The present study of 417 healthy Chinese volunteers examined 129
representative polymorphisms in genes from multiple biological mechanisms in the
regulation of serotonin neurotransmission. A system-level approach using multiple
regression analyses identified that nine SNPs collectively accounted for approximately
8% of the variance in amygdala volume. Permutation analyses showed that the
probability of obtaining these findings by chance was low (p = 0.043, permuted for
1000 times). Findings showed that serotonin genes contribute moderately to individual
differences in amygdala volume in a healthy Chinese sample. These results indicate that
the system-level approach can help us to understand the genetic basis of a complex
trait such as amygdala structure.
Keywords: serotonin, gene, amygdala, brain structure, missing heritability
Introduction
The amygdala, an almond-shaped brain structure which resides in the medial temporal lobe of the
brain (Whalen and Phelps, 2009), is key in emotion processing (Sergerie et al., 2008). Lesion studies
suggest that the amygdala plays a central role in the perception of emotional stimuli (Campanella
et al., 2014), and fMRI studies show that the amygdala activates in response to emotional stimuli
Abbreviations: 5-HT, 5-hydroxytryptamine; 5-HTT, serotonin transporter; 5-HTTLPR, serotonin transporter gene linked
polymorphic region; GWAS, Genome-Wide Association Study; HTR, serotonin receptor; ICV, intracranial volume;
LD, linkage disequilibrium; MAOA, Monoamine oxidase A; MAOB, Monoamine oxidase B; SNP, Single Nucleotide
Polymorphism; TPH, tryptophan hydroxylase; VMAT, Vesicular monoamine transporter; VNTR, variable number tandem
repeat.
Frontiers in Neuroanatomy | www.frontiersin.org 1 October 2015 | Volume 9 | Article 129
Li et al. Serotonergic genes impact amygdala volume
(Habel et al., 2007). Accordingly, the volume of the amygdala
is a widely used index of emotional processing in both animal
and human studies (Yang et al., 2008; Hartley et al., 2011).
Rodent studies have found an association between amygdala
volume and variation in emotion learning (Yang et al., 2008),
while accumulating clinical studies have discovered volume
abnormalities of the amygdala in patients with depression
(Rubinow et al., 2014), bipolar disorder (Lisy et al., 2011),
and borderline personality disorder (Ruocco et al., 2012). For
instance, patients with personality disorder have a 13% smaller
amygdala than healthy controls (Ruocco et al., 2012). Given these
ﬁndings, amygdala volume could be a promising endophenotype
in regards to emotional behavior and related psychiatric diseases.
Moderate to high heritability for amygdala volume (Hulshoﬀ
Pol et al., 2006; Kremen et al., 2010) suggest a signiﬁcant
genetic basis for this trait. The amygdala is densely innervated
by serotonergic ﬁbers (Bauman and Amaral, 2005), and the
inﬂuence of synaptic serotonin on amygdala responsiveness
has been identiﬁed (Fisher et al., 2006; Rhodes et al.,
2007). Accumulating imaging genetics studies have linked
individual diﬀerences in amygdala volume to genes aﬀecting
serotonergic signal. These genes encode proteins involved in
serotonin synthesis (Inoue et al., 2010), reuptake (Frodl et al.,
2008; Stjepanovic et al., 2013), metabolic degradation (Meyer-
Lindenberg et al., 2006), and receptors (Zetzsche et al., 2008).
However, the variance of the amygdala structure explained by
a single genetic locus is small, no more than 1% (Hibar et al.,
2015), far less than the reported 63–66% heritability (Kremen
et al., 2010) from twin studies. This gap might be explained
as the amygdala size, like many complex quantitative traits, is
inﬂuenced by multiple genes, each with a small eﬀect. Therefore,
a gene set based model is needed to assess the additive eﬀects of
a group of functionally related genes that mediate a particular
biological process (i.e., serotonin functioning) and potential
interactions.
In the present study, we applied the system-level approach
developed by our research group (Chen et al., 2015) to evaluate
the overall contribution of the serotonin system genes on
individual diﬀerences in amygdala morphology. A large sample
of 417 Han Chinese adults was recruited, and 129 polymorphic
loci within the serotonin system were genotyped to cover
a substantial portion (by LD) of the common variations in
serotonin system genes, including biosynthesis, vesicular release,
active reuptake, metabolic degradation, and presynaptic and
postsynaptic receptors. We hypothesized that the genes along
the speciﬁed pathway would contribute greatly to variation in
amygdala volume.
Materials and Methods
Participants
Our 417 participants (mean age 20.4 years, SD = 0.9; 179 males
and 238 females) were a subset of a larger study of 480 healthy
Chinese college students (mean age = 19.9 years, SD = 0.9;
208 males and 272 females) from Beijing Normal University,
Beijing, China (Li et al., 2011), for whom structural imaging
data was available. All participants were Han Chinese and were
free of neurological and psychiatric disorders. This study was
approved by the IRB of the State Key Laboratory of Cognitive
Neuroscience and Learning at Beijing Normal University, China.
All experiments were performed in accordance with approved
guidelines and regulations. Written informed consent was
obtained from each participant.
Gene Selection
We selected genes using the serotonin pathway deﬁned in the
Kyoto Encyclopedia of Genes and Genomes database, a collection
of pathway maps widely used in gene-set analysis. Genes in
the following four serotonin subsystems were selected: (1) the
serotonin synthesis subsystem, which converts hydroxylation (by
TPH) to 5-HT: TPH1, TPH2; (2) the degradation subsystem,
which directly breaks down released 5-HT at the synapse into
inactive metabolites (MAOA, MAOB); (3) the transportation
subsystem, which pumps serotonin from synaptic spaces into
presynaptic neurons [SLC6A4(also known as 5-HTT)] or
integrates the membrane of intracellular vesicles of presynaptic
neurons and transported monoamines into the synaptic vesicles
[SLC18A1(also known as VMAT1), SLC18A2(also known as
VMAT2)]; (4) the serotonin receptor subsystem (HTR1A,
HTR1B, HTR1D, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A,
HTR3B, HTR3C, HTR3D, HTR3E, HTR4, HTR5A, HTR5B,
HTR6, HTR7). Together, the selected genes represent all major
genes involved in the four serotonin subsystems in humans
(Chen et al., 2015). Several tag SNPs (tSNPs) deﬁned by
the HapMap project1 [Phase 3] (Frazer et al., 2007) were
selected to sample the genetic diversity of these genes. Details
of these genes and the selected loci (129 polymorphisms,
including 127 SNPs and 2 VNTR polymorphisms) are shown in
Supplementary Table S1.
Genotyping Techniques
Genotyping was conducted as previously described (Li et al.,
2011). Brieﬂy, 4 ml venous blood sample was collected from
each subject, and then genomic DNA was extracted according
to standard methods. SNPs were genotyped using the Illumina
GoldenGate Genotyping protocol (see Illumina GoldenGate
Assay Protocol for details2). In addition, two genetic markers
(5-HTTLPR, MAOA VNTR) were ascertained by standard PCR
procedures (Chen et al., 2015).
Gene Data Preprocessing
Quality control of the genetic data was carried out based on
the larger sample of 480 participants. Two subjects met the
criteria of over 10% null genotyping, and were thus excluded
from subsequent analyses. Of the 60228 genotypes (126 SNPs
by 478 subjects), 120 genotypes (0.2%) were excluded because
of low GenCall (<0.25). If any SNP had fewer than 10 (2%)
heterozygotes or minor homozygotes, these two genotype groups
were combined. If the combined group still had fewer than
10 subjects, that SNP was excluded from further analysis.
1www.hapmap.org
2www.southgene.com.cn
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We found that ﬁve SNPS showed signiﬁcant Hardy–Weinberg
disequilibrium (p< 0.01) based on a df of 1 (for SNPs located on
X chromosome, only females were included in HWE calculation
since males have only one X chromosome). However, these
SNPs were retained because the HW disequilibrium here did
not seem to result from genotyping error but rather reﬂected
the characteristics of college students due to social selection
(i.e., overrepresentation of alleles linked to school achievement
and motivation; Chen et al., 2013). Because both tag SNPs and
additional SNPs in regions detected in recent selection (Hawks
et al., 2007) were selected in the current study, there was high
LD among some SNPs. Thirty SNPs were excluded from multiple
regression analysis because of their high LD with adjacent
SNPs [r2 > 0.8, Plink calculated (Purcell et al., 2007)]. Genetic
relatedness among subjects was checked following Anderson et al.
(2010) protocol by Plink. All genotyped unrelated autosome
SNPs (n = 240, r2 < 0.8) were used and the threshold was set
at 0.95 (personal communication with Dr. Anderson and Dr.
Zondervan). No pair of subjects showed high relatedness (all
PI_HAT smaller than 0.5).
Four-hundred and seventy-eight subjects (99.6%) and 99
polymorphisms (77%) passed all of the aforementioned quality
control procedures. Of these 478 subjects, 417 had structural
imaging data and were thus included in the subsequent analyses
of the 99 polymorphisms. The information for all 129 loci
(127 SNPs and 2 VNTRs) is shown in Supplementary Table
S1, including location (rs number, chromosome, position), gene,
serotonin subsystem, allele polymorphism and frequency, HWE,
LD, and whether they were included in the main analyses.
MRI Data Collection
MRI scans were performed in a 3.0T Siemens Magnetom Trio
scanner equipped with a standard head coil at Beijing Normal
University Brain Imaging Center. Structural MRI data were
acquired with the T1-weighted MPRAGE pulse sequence
(TE = 3.75 ms, TR = 2,530 ms, ﬂip angle = 7◦, FOV = 256 mm
× 256 mm, voxel size = 1 mm × 1 mm × 1.33 mm, number of
partitions = 128).
MRI Data Processing
Cortical surface reconstruction and volumetric segmentation
were performed with the FreeSurfer software3 (Version 4.5.0).
Each subject’s average T1-weighted image was segmented into
gray matter volumes for seven subcortical regions relying upon
variations in voxel signal intensities, probabilistic atlas location
and local spatial relationships between the structures (Fischl et al.,
2002). Quality control of scan images and segmentation was
assured by visual inspection of the whole cortex of each subject,
and any inaccuracies in Talairach-transformation, skull stripping
and segmentation were manually corrected and re-inspected.
High correlations between the automatic measures and manual
measures in vivo and ex vivo have been demonstrated (Desikan
et al., 2006). The amygdala volumes obtained from the Freesurfer
procedure have been reported to be signiﬁcantly correlated with
manual parcellation (Stjepanovic et al., 2013).
3http://surfer.nmr.mgh.harvard.edu
Volumes of bilateral amygdala were retracted from the
standard output of the FreeSurfer analysis. Then the mean
bilateral amygdala volume was calculated. A preliminary
analysis showed that both gender and ICV were signiﬁcantly
associated with amygdala size (for gender, F(1,415) = 48.06,
p= 1.59× 10−11; for ICV, F(1,415)= 114.23, p= 1.03 × 10−23).
Therefore, to control for the confounding eﬀects of gender
and ICV, a regression analysis was conducted, with gender
and ICV as independent variables, and amygdala size as the
dependent variable. The residual for each subject was normally
distributed (skewness = 0.456, kurtosis = 0.747, Kolmogorov–
Smirnov test = 0.039, p = 0.136) and was used as an index of
amygdala volume in subsequent association analyses. To avoid
the possible confounding eﬀect of emotion state on amygdala
structure, the associations between Beck Anxiety Inventory (BAI)
and Beck Depression Inventory (BDI) scores with amygdala size
were tested separately. The associations did not reach signiﬁcance
[for BAI, F(1,415) = 0.74, p = 0.39; for BDI, F(1,415) = 2.67,
p= 0.10]. Therefore, the BAI and BDI scores were not considered
in subsequent analyses.
Statistical Analysis
The statistical procedure was comprised of three major analyses.
First, analysis of variance (ANOVA) was conducted for each of
these loci to detect variants which met the inclusion criterion
(p< 0.05, uncorrected, to control for Type II error). Second, these
loci were then entered into a regression model to estimate their
overall contribution to amygdala size. In the regression model,
all loci with signiﬁcant main eﬀects based on the ANOVA results
were included with a forward stepwise method. In this step, all
SNPs were coded in a linear way, i.e., the major homozygote,
heterozygote, and minor homozygote were coded into 1, 2, and
3, respectively (SNPs on X chromosome were coded as 1 and 3
for major and minor allele homozygote, and also 3 for female
heterozygotes). In addition, the MAOA VNTR was coded as 1
for the 3 repeat and 3 for the 4 repeat in males and 1 for 3
repeat homozygotes and 3 for others in females. Finally, the
regression model was veriﬁed by permutation. Permutation tests
were done 1000 times by shuﬄing amygdala volume data across
subjects. In each iteration, selection of signiﬁcant snps from
the ANOVA tests, regression model estimation with a forward
stepwise method, and r2 calculation were carried out on the
shuﬄed data. The probability of getting a larger r2 in the shuﬄed
data than in the real data was deﬁned as p-value of the model.
Results
The mean bilateral amygdala volume across subjects was
1700.5 mm3 (SD = 177.7 mm3). ANOVA was used to screen the
99 loci that passed quality control procedures for associations
with the amygdala size. Nine SNPs showed main eﬀects on
amygdala volume with uncorrected p < 0.05. Speciﬁcally,
individuals who were major allele homozygotes for rs7997012
(HTR2A), rs7984966 (HTR2A), rs939334 (HTR3D), rs10917509
(HTR6), or rs363226 (SLC18A2), or minor allele homozygotes for
rs1487275 (TPH2), rs6792482 (HTR3D), rs11676829 (HTR5B),
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or rs12249377 (HTR7), tended to have larger amygdala size
than the remaining groups. (For details, see Table 1, and online
Supplementary Table S2 ).
These nine SNPs were added to a regression model using the
forward stepwise procedure to estimate their overall contribution
to amygdala size. ﬁve of them made signiﬁcant and unique
contributions to the ﬁnal model, while the other four SNPs
were not included because of collinearity with other SNPs
(see Table 2). The regression model accounted for 8.2% (6.8%
adjusted) of the variance in amygdala size [F(5,417) = 7.33,
p = 1.3 × 10−6]. The conﬁdence interval of R2 estimated by
bootstrap for 1000 times was 0.04–0.16, and that for adjusted R2
was 0.03–0.15.
Finally Monte Carlo permutation analyses were carried out to
test the model. Figure 1 shows the permutation results. Based
on 1000 permutation tests, the probability of attaining the R2 or
adjusted R2 found in the model reached signiﬁcance (p = 0.043
and 0.044, respectively). These results indicate that genes in the
serotonin system contribute substantially to individual variance
in amygdala volume.
Discussion
The current study combined the advantages of both the candidate
gene approach and dense genotyping technology. Our theory-
drivenmethod detected a group of biological relevant genes based
on prior knowledge and thus avoided the heavy comparison
correction necessary in GWAS. However, unlike candidate gene
studies on single genes, our system level approach took into
account the polygenic nature of amygdala structure. Given the
innervation of serotonergic ﬁbers in the amygdala (Bauman and
Amaral, 2005) and the role of serotonergic genes on amygdala
structure (Meyer-Lindenberg et al., 2006; Frodl et al., 2008;
Zetzsche et al., 2008), we used dense gene chips to cover all
tag SNPs of the serotonergic biological pathway in order to test
the additive eﬀect of potential genes. Results suggest that such
a system level approach could bridge the gap between the small
contributions of single genes and the considerable heritability
of amygdala volume revealed by twin studies. Speciﬁcally,
serotonergic genes collectively accounted for 8.2% of variance in
amygdala volume. Although associations between these speciﬁc
SNPs and amygdala structure have not been reported before,
direct and indirect evidence have linked these genes to amygdala
structure and amygdala-related psychological disorders. In the
following paragraphs, we discuss each of these genes.
The TPH2 gene encodes TPH protein which is involved in
the rate-limiting biosynthesis of serotonin. Postmortem studies
have revealed the expression of TPH2 mRNA in the amygdala
(Zill et al., 2007). Raphe neurons of Tph2 knockout mice
were completely devoid of 5-HT, indicating that brain 5-HT
synthesis across the lifespan is exclusively maintained by TPH2
(Gutknecht et al., 2009). Previous imaging genetic studies also
found associations between several TPH SNPs and the amygdala,
such as rs4570625 with the structure (Inoue et al., 2010) and
function (Furmark et al., 2009) of the amygdala, and rs17110563
with bipolar disorder (Cichon et al., 2008). Thus far, however, TA
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TABLE 2 | Regression model for amygdala volume with genetic data.
Regressor Gene B T p
rs10917509 HTR6 −21.16 −2.56 0.01
rs11676829 HTR5B 48.88 3.00 0.00
rs6792482 HTR3D 30.62 2.73 0.01
rs363226 SLC18A2(VMAT2) −58.70 −2.73 0.01
rs7984966 HTR2A −65.77 −2.30 0.02
‘Gene’ is the corresponding gene for each SNP; ‘B’ is the regression coefficient,
‘T’ and ‘p’ are t-test results. Effects of gender and ICV are controlled prior to this
analysis.
FIGURE 1 | Permutation results for the genetic model: the dashed line
represents the empirical distribution of R2 obtained from the
randomized data, and the solid vertical line represents R2 obtained
from the actual data.
no study has linked rs1487275 genotype to any emotion-related
behavior or psychiatric disease, although its eﬀect on amygdala
structure was identiﬁed in the current study. Therefore, future
studies should explore such potential associations in healthy or
clinical samples.
SLC18A2 encodes VMAT2 that transports free serotonin from
cellular cytosol into synaptic vesicles (Eiden et al., 2004). Rodent
studies have reported early expression of VMAT2 in amygdala
(Lebrand et al., 1998) and that mice lacking one copy of the
VMAT2 gene develop with signiﬁcantly reduced serotonin (Fon
et al., 1997). Convergent studies have linked VMAT2 gene to
brain development and amygdala-related psychiatric diseases.
For instance, an increase in cell death in the superﬁcial layers of
the cingulate and retrosplenial cortices during early postnatal life
in Vmat2 knockout mice (Stankovski et al., 2007) and a delayed
maturation of the upper cortical layers in the Vmat2(sert-cre)
andTph2(−/−) mice (Narboux-Nême et al., 2013) were reported.
Moreover, VMAT2 heterozygous mice exhibit ‘depression-like’
phenotype (Fukui et al., 2007). In human studies, patients with
bipolar disorder showed higher binding of VMAT2 (Zubieta
et al., 2001), patients with major depression also showed elevated
VMAT2 density (Zucker et al., 2002) and structural change of
VMAT2 (Zalsman et al., 2011) in platelets. Our ﬁnding of an
association between SLC18A2 variation and the structure of the
amygdala seems in accordance with the above previous results.
HTR2A, HTR3D, HTR5B, HTR6, and HTR7 encode diﬀerent
serotonin receptors. Studies indicated the expression of HTR2A
(McDonald and Mascagni, 2007), HTR3 (Morales et al., 1998),
HTR6 (Marazziti et al., 2012) in the amygdala. Their eﬀects
on amygdala structure might be partly accounted for by
the distribution of serotonin receptors in the amygdala, and
the modulation eﬀect of serotonin receptors on diﬀerent
developmental processes (Gaspar et al., 2003), such as
neurogenesis, apoptosis, axon branching, and dendritogenesis.
Accumulating pharmacological studies have linked these
receptors to the function of the amygdala and related psychiatric
diseases. For example, HTR2 agonist has been found to increase
neuronal ﬁring of the amygdala (Stein et al., 2000) and to increase
anxiety-like behavior (Pockros-Burgess et al., 2014); HTR2A
antagonist can have an antidepressant-like eﬀect (Quesseveur
et al., 2013); HTR3 agonist attenuates antidepressants’ eﬀect
(Nakagawa et al., 1998), whereas HTR3 antagonist as well as
HTR6 and HTR7 have an antidepressant eﬀect (Wesolowska
and Nikiforuk, 2007; Mnie-Filali et al., 2011; Gupta et al.,
2014). A recent study also showed that social isolation stress
could result in up-regulation of HTR5B, suggesting a close
link between HTR5B and emotion and its neural substrates
such as the amygdala (Maekawa et al., 2010). In addition to
pharmacological studies, at least one molecular genetic study
found a signiﬁcant association between rs7997012 variation
(HTR2A) and the therapeutic response to antidepressant
treatments in major depression patients (Lin et al., 2014). In
sum, previous studies have consistently shown that the above
serotonin receptors play a major role in mood disorders, which
are likely related to amygdala dysfunction. Moreover, HTR6 was
indicated to mediate brain development in MAOA-deﬁcient
mouse embryos (Wang et al., 2014) and HTR7 signaling was
reported to regulate neuronal morphology (Kobe et al., 2012).
These documented genetic eﬀects on neural development may
have a permanent impact on the size of the amygdala. Given that
the formation of serotonergic neurons and ﬁber distribution are
not impaired (Gutknecht et al., 2008) inTph2 knockout mice
(that are completely deﬁcient in brain serotonin synthesis), we
inferred that the eﬀect of these genes on amygdala size was not
through serotonergic neurons but through serotonin level and
its eﬀect on brain development. In the developing nervous
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system, an excess of serotonin aﬀects interneuron migration
(Riccio et al., 2009) and neocortical pyramidal neuron migration
(Riccio et al., 2011). High levels of serotonin are also suggested
to have neuroprotective eﬀects on cortical neurons (Stankovski
et al., 2007), while lack of brain serotonin is suggested
to aﬀect postnatal development and serotonergic neuronal
circuitry formation (Migliarini et al., 2013). In summary, the
association that we found between serotonergic genes and
amygdala structure might result from the developmental role of
serotonin.
Further research is required to support our ﬁndings for several
reasons. First, some serotonergic genes, which have been found in
several studies to impact amygdala structure, were not found to
impact amygdala morphology in the present study (e.g.,HTR1A).
One possible explanation is that HTR1A may be important
in amygdala structure and function in Caucasians (for whom
most previous studies were on), but not Chinese. We were not
surprised at the negative result in our Han Chinese sample, as
several studies have reported that the same genetic variation
can result in divergent psychological outcomes, depending on
the population (Long et al., 2013; Wang et al., 2013). For
example, a recent study genotyped the HTR1A polymorphism
in European Americans and Koreans, and reported a signiﬁcant
interaction between HTR1A genotype and culture in the locus of
attention (Kim et al., 2010). Moreover, the association between
the HTR1A gene polymorphism (rs6295) and bipolar disorder
in the Caucasian sample (Sullivan et al., 2009) was not found
in the Korean population (Kim et al., 2014). Therefore, our
sample of pure Han Chinese helps to prevent the confounding
eﬀect of population, but we should be cautious as it also limits
the generalization of our results to other populations. Another
possible explanation is that we may have missed the causative
SNPs by using only tag SNPs to sample the genetic diversity of
these genes. Further studies are required to test this association
in other populations and to genotype more SNPs.
Second, in the current study, we focused on the role
of serotonergic genes in healthy young adults to avoid the
confounding eﬀects of neurological diseases and age (Filippini
et al., 2009). However, it should be noted that both developmental
mechanisms and adult chronic disease may aﬀect amygdala
size, but through diﬀerent mechanisms. Studies involving larger
sample sizes and older adults (to explore possible eﬀects of aging)
and subjects with chronic disease are needed. Third, considering
that amygdala dysfunction accompanying structural abnormality
also underlies emotion related psychiatric disorders (Ubl et al.,
2015) and reﬂects the eﬀect of serotonergic genes (Hariri et al.,
2002), further studies are needed to test the functional indices of
the amygdala. Also, studies on amygdala subregions using higher
resolution images could provide more information regarding the
eﬀects of serotonergic genes on the amygdala. Fourth, the current
study could not identify the speciﬁc serotonin receptor(s) that
transduced the eﬀects. More direct biological evidence is required
in further studies to elucidate the relationship between the
serotonergic receptors and the downstream amygdala structural
change.
Last but not the least, all associated SNPs in our study
were located in non-coding regions. This result is consistent
with the view that non-coding regions which were once labeled
as “junk DNA” actually may play important functional roles
(Birney et al., 2007). Some studies indicate that intron variants
are involved in gene expression (Zhang et al., 2007) or mRNA
secondary structure formation (Nackley et al., 2006). To explore
the speciﬁc roles of the SNPs screened in our study, more
systematic studies using animal models and other techniques
(e.g., optogenetics) are required. Third, although genes from
the serotonin system accounted for 8.2% of the variance in
amygdala volume, there is still much more “missing heritability”
(8.2% vs. 63–65% heritability) to be accounted for. Future
studies regarding amygdala structure should incorporate other
genetic systems, environmental factors, genetic epistasis, and
gene-environmental interactions.
Conclusion
Our system-level approach indicated that several genes within
the serotonin system had small eﬀects on amygdala structure,
and these genes together accounted for a sizable portion of
the missing heritability of amygdala volume. The system-level
analysis may enhance our understanding of the genetic basis
of human amygdala structure and amygdala-related emotional
behaviors and psychiatric diseases.
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